Marshall Wace’s Gilead Sciences GILD Stock Holding History

Marshall Wace’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100	Closed	-$12.3K	–	3391
2025 Q4	$12.3K	Hold	100	–	–	﹤0.01%	2849
2025 Q3	$11.1K	Buy	+100	New	+$11.4K	﹤0.01%	2801
2023 Q3	–	Sell	-191,200	Closed	-$14.7M	–	2378
2023 Q2	$14.7M	Buy	+191,200	New	+$15.2M	0.03%	591
2023 Q1	–	Sell	-37,400	Closed	-$3.21M	–	2827
2022 Q4	$3.21M	Buy	37,400 +3,000	+9%	+$238K	0.01%	1460
2022 Q3	$2.12M	Buy	+34,400	New	+$2.17M	﹤0.01%	1970
2022 Q1	–	Sell	-59,600	Closed	-$4.33M	–	3577
2021 Q4	$4.33M	Sell	59,600 -45,700	-43%	-$3.15M	0.01%	1472
2021 Q3	$7.36M	Buy	105,300 +88,900	+542%	+$6.25M	0.03%	733
2021 Q2	$1.13M	Buy	+16,400	New	+$1.1M	0.01%	1754

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Marshall Wace's GILD Position: Q1 2026 in Review

Marshall Wace increased its Gilead Sciences (GILD) stake by 191% in Q1 2026, buying an estimated $212M and bringing the position to 2,310,515 shares worth $322M. The position accounts for 0.32% of the portfolio, ranked #37.

Marshall Wace first reported a position in GILD in Q1 2014 and has held it in 41 quarters since. The position peaked at $421M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Marshall Wace held 2,310,515 shares of Gilead Sciences worth $322M as of Q1 2026.
Marshall Wace bought 1,517,130 Gilead Sciences shares in Q1 2026, an estimated $212M.
Gilead Sciences made up 0.32% of Marshall Wace's portfolio in Q1 2026, its #37 holding.
Marshall Wace first reported a position in Gilead Sciences in Q1 2014 and has held it in 41 quarters since.
Marshall Wace's Gilead Sciences position peaked at $421M in Q1 2023.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.